Stevioside significantly reduced cancer cell viability (MTT assay) in a dose-dependent manner. Induced apoptosis via increased Caspase-3 expression and decreased Bcl-2 and Mcl-1 expression (anti-apoptotic genes). Dose-dependent apoptosis induction (p < 0.05). This evidence concerns the gene BCL2 and cancer.